Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention
- 31 January 2005
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 15 (1), 72-79
- https://doi.org/10.1016/j.nmd.2004.09.009
Abstract
No abstract availableKeywords
Funding Information
- French Muscular Dystrophy Association
This publication has 55 references indexed in Scilit:
- Glucocorticoid corticosteroids for Duchenne muscular dystrophyPublished by Wiley ,2004
- Long-term linear growth of children with severe steroid-responsive nephrotic syndromePediatric Nephrology, 2003
- Cola Beverage Consumption Induces Bone Mineralization Reduction in Ovariectomized RatsArchives of Medical Research, 2000
- Deficient Bone Formation in Idiopathic Juvenile Osteoporosis: A Histomorphometric Study of Cancellous Iliac BoneJournal of Bone and Mineral Research, 2000
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Calcium and vitamin D for corticosteroid‐induced osteoporosisCochrane Database of Systematic Reviews, 1998
- Effects of dairy products on bone and body composition in pubertal girlsThe Journal of Pediatrics, 1995
- Deflazacort in Duchenne dystrophy: Study of long‐term effectMuscle & Nerve, 1994
- 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: Short-term effects on serum osteocalcin levels and bone mineral densityThe Journal of Pediatrics, 1991
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989